Protective Mechanisms of Simvastatin in Experimental Periodontal Disease

被引:55
作者
Dalcico, Roberta [1 ]
de Menezes, Adriana M. A. [1 ]
Deocleciano, Otacilio B. [1 ]
Oria, Reinaldo B. [2 ]
Vale, Mariana L. [1 ]
Ribeiro, Ronaldo A. [1 ]
Brito, Gerly A. de C. [2 ]
机构
[1] Univ Fed Ceara, Dept Physiol & Pharmacol, BR-60416030 Fortaleza, Ceara, Brazil
[2] Univ Fed Ceara, Dept Morphol, BR-60416030 Fortaleza, Ceara, Brazil
关键词
Alveolar bone loss; hydroxymethylglutaryl-CoA reductase inhibitors; inflammation; periodontitis; ALVEOLAR BONE LOSS; KAPPA-B LIGAND; NITRIC-OXIDE; OVARIECTOMIZED RATS; PROTEIN PRENYLATION; MEVALONATE PATHWAY; IN-VITRO; STATINS; INFLAMMATION; METABOLISM;
D O I
10.1902/jop.2012.120114
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Simvastatin is a cholesterol-lowering drug whose pleiotropic effects may have a therapeutic impact on bone. This study evaluates the effect of simvastatin on rats subjected to experimental periodontal disease. Methods: Periodontitis was induced by ligature placement around the maxillary left second molar of rats for 11 days. Groups of six animals received oral saline or simvastatin (3, 10, and 30 mg/kg/day) until sacrifice on day 11. Alveolar bone loss was determined by macroscopic and histologic examination. The serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total alkaline phosphatase (TAP) were evaluated. Gingival myeloperoxidase activity and gingival levels of interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha, IL-10, reduced glutathione, malonaldehyde, and nitrate/nitrite were analyzed to investigate oxidative stress and inflammation. Expression of inducible nitric oxide synthase (iNOS), matrix metalloproteinases 1 and 8 (MMP-1 and -8), bone morphogenetic protein-2 (BMP-2), receptor activator of nuclear factor kappa B (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) were also investigated by immunohistochemistry to assess bone turnover and metabolism. Immunofluorescence microscopy was used to confirm the expression of RANKL in rats' maxillae. Results: Treatment with simvastatin improved alveolar bone loss within all of the parameters studied, thus demonstrating anti-inflammatory and antioxidant activity. Simvastatin reduced expression of iNOS, MMP-1 and -8, RANK, and RANKL and increased BMP-2 and OPG levels in the periodontal tissue. Simvastatin (30 mg/kg) increased TAP activity on day 11 compared with the saline group. No differences were found in the levels of AST and ALT in any of the groups studied. Conclusion: The present data suggest that simvastatin prevents inflammatory bone resorption in experimental periodontitis, which may be mediated by its anti-inflammatory and antioxidant properties.
引用
收藏
页码:1145 / 1157
页数:13
相关论文
共 50 条
[1]  
Abel T, 2009, MED SCI MONITOR, V15, pMS6
[2]   Statins as antiinflammatory and immunomodulatory agents - A future in rheumatologic therapy? [J].
Abeles, AM ;
Pillinger, MH .
ARTHRITIS AND RHEUMATISM, 2006, 54 (02) :393-407
[3]   Simvastatin Improves Epithelial Dysfunction and Airway Hyperresponsiveness From Asymmetric Dimethyl-Arginine to Asthma [J].
Ahmad, Tanveer ;
Mabalirajan, Ulaganathan ;
Sharma, Amit ;
Aich, Jyotirmoi ;
Makhija, Lokesh ;
Ghosh, Balaram ;
Agrawal, Anurag .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2011, 44 (04) :531-539
[4]   Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-κB ligand through modulation of NF-κB pathway [J].
Ahn, Kwang Seok ;
Sethi, Gautam ;
Chaturvedi, Madan M. ;
Aggarwal, Bharat B. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (08) :1733-1740
[5]   S-Nitrosoglutathione Decreases Inflammation and Bone Resorption in Experimental Periodontitis in Rats [J].
Andrade de Menezes, Adriana Magalhaes ;
Pereira de Souza, Gabriela Freitas ;
Gornes, Antoniella Souza ;
de Carvalho Leitao, Renata Ferreira ;
Ribeiro, Ronaldo de Albuquerque ;
de Oliveira, Marcelo Ganzarolli ;
de Castro Brito, Gerly Anne .
JOURNAL OF PERIODONTOLOGY, 2012, 83 (04) :514-521
[6]   Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats [J].
Ayukawa, Yasunori ;
Yasukawa, Eisuke ;
Moriyama, Yasuko ;
Ogino, Yoichiro ;
Wada, Hiroko ;
Atsuta, Ikiru ;
Koyano, Kiyoshi .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2009, 107 (03) :336-342
[7]   Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation [J].
Barter, Matt J. ;
Hui, Wang ;
Lakey, Rachel L. ;
Catterall, John B. ;
Cawston, Tim E. ;
Young, David A. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) :2189-2198
[8]   Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats [J].
Bezerra, MM ;
de Lima, V ;
Alencar, VBM ;
Vieira, IB ;
Brito, GAC ;
Ribeiro, RA ;
Rocha, FAC .
JOURNAL OF PERIODONTOLOGY, 2000, 71 (06) :1009-1014
[9]   Mevalonate pathway: A review of clinical and therapeutical implications [J].
Buhaescu, Irina ;
Izzedine, Hassane .
CLINICAL BIOCHEMISTRY, 2007, 40 (9-10) :575-584
[10]   Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization [J].
Crisby, M ;
Nordin-Fredriksson, G ;
Shah, PK ;
Yano, J ;
Zhu, J ;
Nilsson, J .
CIRCULATION, 2001, 103 (07) :926-933